Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abete, P., Bianco, S., Calabrese, C., Napoli, C., Cacciatore, F., Ferrara, N., and Rengo, F. Effects of melatonin in isolated rat papillary muscle. FEBS Lett. 412:79–85, 1997.
Behar, S., Halabi, M., Reicher-Reiss, H., Zion, M., Kaplinsky, E., Mandelzweig, L., and Goldbourt, U. Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am. J. Med. 94:395–400, 1993.
Birau, N., Petterssen, U., Meyer, C., and Gottschalk, J. Hypotensive effect of melatonin in essential hypertension. IRCS Med. Sci. 9:906.
Bosman, H., Dormehl, I.C., Hugo, N., Redelinghuys, I.F., and Theron, J.J. The effect of intravenous administration of melatonin on cardiovascular parameters of the baboon Papio ursinus. J. Pineal Res.11:179–181, 1991.
Brugger, P., Marktl, W., and Herold, M. Impaired nocturnal secretion of melatonin in coronary heart disease. The Lancet 345:1408, 1995.
Brun, J., Claustrat, B., Saddier, P., and Chazot, G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 15:136–139, 1995.
Cagnacci, A., Arangino, S., Angiolucci, M., Maschio, E., and Melis, G.B. Influences of melatonin administration on the circulation of women. Am. J. Physiol. 43:R335–R338, 1998.
Chan, T.Y. and Tang, P.L. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocrine Res. 21:681–696, 1995.
Capsoni, S., Viswanathan, M., de Oliveira, A.M., and Saavedra, J.M. Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis. Endocrinol. 135:373–378, 1994.
Capsoni, S., Stankov, B.M., and Fraschini, F. Reduction of regional cerebral blood flow by melatonin in young rats. NeuroReport 6:1346–1348, 1995.
Chuang, J.I., Chen, S.S., and Lin, M.T. Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats. Pharmacol. 47:91–97, 1993.
Cunnane, S.C., Manku, M.S., Oka, M., and Horrobin, D.F. Enhanced vascular reactivity to various vasoconstrictor agents following pinealectomy in the rat: role of melatonin. Can. J. Physiol. Pharmacol. 58:287–293, 1980.
Doolen, S., Duckles, S.P., Geary, G.G., and Krause, D.N. Melatonin mediates vascular dilation via a distinct melatonin receptor sub-type. Soc. Neurosci. Abstr. 23:1517, 1997.
Doolen, S., Krause, D.N., Dubocovich, M.L., and Duckles, S.P. Melatonin mediates two distinct responses in vascular smooth muscle. Eur. J. Pharmacol. 345:67–69, 1998a.
Doolen, S., Krause, D.N., and Duckles, S.P. Gender differences in response to melatonin. Soc. Neurosci.Abstr. 21:1406, 1995.
Doolen, S., Krause, D.N., and Duckles, S.P. Estradiol modulates vascular response to melatonin in rat caudal artery. Am. J. Physiol. 276:H1281–1288, 1999.
Dubocovich, M.L., Cardinali, D.P., Guardiola-Lemaitre, B., Hagan, R.M., Krause, D.N., Sugden, D., Yocca, F.D., and Vanhoutte, P.M. Melatonin Receptors. The IUPHAR Compendium of Receptor Characterization and Classification. IUPHAR Media, London, 1998, pp. 187–193.
Dubocovich, M.L., Masana, M.I., Iacob, S., and Sauri, D.M. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg’s Arch. Pharmacol.355:365–375, 1997
Duckles, S.P., Barrios, V.E., Doolen, S., and Krause, D.N. Melatonin receptors potentiate contractile responses to adrenergic nerve stimulation in rat caudal artery. Proc. West. Pharmacol. Soc. 38:101–102, 1995.
Esquifino, A., Agrasal, C., Velazquez, E., Villanua, M.A., and Cardinali, D.P. Effect of melatonin on serum cholesterol and phospholipid levels, and on prolactin, thyroid-stimulating hormone and thyroid hormone levels, in hyperprolactinemic rats. Life Sciences 61:1051–1058, 1997.
Evans, B.K., Mason, R., and Wilson, V.G. Evidence for direct vasoconstriction of melatonin in “pressurized” segments of isolated caudal artery from juvenile rats. Naunyn-Schmiedebergs Arch. Pharmacol.346:362–365, 1992.
Fiorina, P., Lattuada, G., Ponari, O., Silvestrini, C., and Dall’Aglio, P. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. The Lancet 347:692–693, 1996.
Gallerani, M., Manfredini, R., Ricci, L., Cocurullo, A., Goldoni, C., Bigoni, M., and Fersini, C. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol. Scand. 87:482–487, 1993.
Geary, G.G., Krause, D.N., and Duckles, S.P. Melatonin directly constricts rat cerebral arteries through modulation of potassium channels. Am. J. Physiol. 273:H1530–H1536, 1997.
Geary, G.G., Duckles, S.P., and Krause, D.N. Effect of melatonin in the rat tail artery: Role of K+ channels and endothelial factors. Br. J. Pharmacol. 123:1533–1540, 1998.
Holmes, S.W. and Sugden, D. The effect of melatonin on pinealectomy-induced hypertension in the rat. Br. J. Pharmacol. 56:360P, 1976.
Hutcheson, I.R. and Griffith, T.M. Heterogeneous population of K+ channels mediate EDRF release to flow but not agonists in rabbit aorta. Am. J. Physiol. 266:H590–H596, 1994.
K.-Laflamme, A., Wu, L.Y., Foucart, S., and de Champlain, J. Impaired basal sympathetic tone and alpha 1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am. J. Hypertension 11:219–229, 1998.
Karppanen, H., Airaksinen, M.M., and Sarkimaki, I. Effects in rats of pinealectomy and oxypertine on spontaneous locomotor activity and blood pressure during various light schedules. Ann. Med. Exp. Biol. Fenn. 51:93, 1973.
Kawashima, K., Miwa, Y., Fujimoto, K., Ochata, H., Nishino, H., and Koike, H. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin. Exp. Hypertens. Ther. Pract. A9:1121–1131, 1987.
Kitay, J.I. and Altschule, M.D. The Pineal Gland, A Review of the Physiologic Literature, Harvard University Press, Cambridge, MA, pp. 69–70,1954.
Kelly-Hayes, M., Wolf, P.A., Kase, C.S., Brand, F.N., McGuirk, J.M., and D’Agostino, R.B. Temporal patterns of stroke onset. The Framingham Study. Stroke 26:1343–1347, 1995.
Krause, D.N. and Dubocovich, M.L. Regulatory sites in the melatonin system of mammals. Trends Neurosci. 13:464–470, 1990.
Krause, D.N. and Dubocovich, M.L. Melatonin receptors. Ann. Rev. Pharmacol. Toxicol. 31:549–568, 1991.
Krause, D.N., Barrios, V.E., and Duckles, S.P. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur. J. Pharmacol. 276:207–213, 1995.
Krause, D.N., Doolen, S., and Duckles, S.P. Vascular melatonin receptor subtypes: function, pharmacology and effect of estrogen. Naunyn-Schmiedeberg’s Arch. Pharmacol. 358 (Suppl. 1):R550, 1998.
Krause, D.N., Dubocovich, M.L., Edvinsson, L., Geary, G.G., Masana, M.I., and Duckles, S.P. ML1A melatonin receptors in human and rat cerebral and peripheral arteries: mRNA expression and functional pharmacology. Soc. Neurosci. Abstr. 22:1400, 1996.
Laitinen, J.T., Viswanathan, M., Vakkuri, O., and Saavedra, J.M. Differential regulation of the rat melatonin receptors: selective age-associated decline and lack of melatonin-induced changes. Endocrinology 130:2139–2144, 1992
Mahle, C.D., Goggins, G.D., Agarwal, P., Ryan, E., and Watson, A.J. Melatonin modulates vascular smooth muscle tone. J. Biol. Rhythms 12:690–696, 1997.
Masana, M.I., Al-Ghoul, W., and Dubocovich, M.L. MT1 and MT2 melatonin receptor expression in mammalian vasculature and superior cervical ganglion. Naunyn-Schmiedeberg’s Arch. Pharmacol. 358 (Suppl. 1):R72, 1998.
Maywood, E.S., Bittman, E.L., Ebling, F.J., Barrett, P., Morgan, P., and Hastings, M.H. Regional distribution of iodomelatonin binding sites within the suparchiasmatic nucleus of the Syrian hamster and the Siberian hamster. J. Neuroendocrinol. 7:215–223, 1995.
Nelson, M.T. and Quayle, J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268:C799–C822.
Regrigny, O., Delagrange, P., Scalbert, E., Atkinson, J., and Lartaud-Idjouadiene, I. Melatonin improves cerebral circulation security margin in rats. Am. J. Physiol. 275:H139–H144, 1998.
Satake, N., Shibata, S., and Takagi, T. The inhibitory action of melatonin on the contractile response to 5-hydroxytryptamine in various isolated vascular smooth muscles. Gen. Pharmacol. 17553–558, 1986.
Satake, N., Oe, H., Sawada, T., and Shibata, S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen. Pharmacol. 22:219–222, 1991.
Seltzer, A., Viswanathan, M., and Saavedra, J.M. Melatonin-binding sites in brain and caudal arteries of the female rat during the estrous cycle and after estrogen administration. Endocrinology 1301896–1902, 1992
Shibata, S., Satake, N., Takagi, T., and Usui, H. Vasorelaxing action of melatonin in rabbit basilar artery. Gen.Pharmacol. 20:677–680, 1989.
Stankov, B., Capsoni, S., Lucini, V., Pauteck, J., Gatti, S., Gridelli, B., Biella, G., Cozzi, B., and Fraschini, E Autoradiographic localization of the putative melatonin receptor in the brains of two old world primates: Cercopithecus wethiops and Papio ursinus. Neuroscience 52:459–468, 1993.
Terzolo, M., Piovesan, A., Puligheddu, B., Torta, M., Osella, G., Paccoti, P., and Angeli, A. Effects of long-term, low-dose, time-specified melatonin administration on endocrine and cardiovascular variables in adult men. J. Pineal Res. 9:113–124, 1990.
Ting, K.N., Dunn, W.R., Davies, D.J., Sugden, D., Delegrange, P., Guardiola-Lemaitre, B., Scalbert, E., and Wilson, V.G. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. Br. J. Pharmacol. 122:1299–1306, 1997.
Veerman, D.P., Imholz, B.P., Wieling, W., Wesseling, K.H., and van Montfrans, G.A. Circadian profile of systemic hemodynamics. Hypertension 26:55–59, 1995.
Viswanathan, M., Hissa, R., and George, J.C. Suppression of sympathetic nervous system by short photoperiod and melatonin in the Syrian hamster. Life Sci. 38:73–79, 1986.
Viswanathan, M., Laitinen, J.T., and Saavedra, J.M. Expression of melatonin receptors in arteries involved in thermoregulation. Proc. Natl. Acad. Sci. USA 87:6200–6203, 1990.
Viswanathan, M., Laitinen, J.T., and Saavedra, J.M. Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology 56:864–870, 1992.
Viswanathan, M., Scalbert, E., Delagrange, P., Guardiola-Lemaitre, B., and Saavedra, J.M. Melatonin receptors mediate contraction of a rat cerebral artery. Neuroreport 8:3847–3849, 1997.
Weekley, L.B. Pharmacological studies on the mechanism of melatonin-induced vasorelaxation in rat aorta. J. Pineal Res. 19:133–138, 1995.
Zanaboni, A. and Zanaboni-Muciaccia, W. Experimental hypertension in pinealectomized rats. Life Sci. 6:2327–2331, 1967.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Krause, D.N., Geary, G.G., Doolen, S., Duckles, S.P. (2002). Melatoninand Cardiovascular Function. In: Olcese, J. (eds) Melatonin After Four Decades. Advances in Experimental Medicine and Biology, vol 460. Springer, Boston, MA. https://doi.org/10.1007/0-306-46814-X_32
Download citation
DOI: https://doi.org/10.1007/0-306-46814-X_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46134-7
Online ISBN: 978-0-306-46814-8
eBook Packages: Springer Book Archive